Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma [Phase 3]
A Phase 3 clinical trial evaluating tinengotinib versus physician's choice for FGFR-altered cholangiocarcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 [Phase 2]
Phase 2 FLUOPANC trial evaluating fluorescence-guided surgery for pancreatic adenocarcinoma and cholangiocarcinoma using the fluorescent age…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
A clinical trial is enrolling a cohort of patients with hepatocellular carcinoma or cholangiocarcinoma.
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma [NA]
This NOT_YET_RECRUITING clinical trial is evaluating a three-drug combination of irinotecan liposome, capecitabine, and lenvatinib in biliar…
-
CLINICAL_TRIALS withdrawal · 2024-06-12Clinical Trial Update: Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care [NA]
The clinical trial evaluating acupuncture and Chinese herbal medicine in palliative care for cancer patients has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement [Phase 2]
Clinical trial update on a Phase 2 study of pemigatinib for advanced/metastatic or surgically unresectable cholangiocarcinoma, including FGF…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations [Phase 3]
Phase 3 trial of BGJ398 (infigratinib) in first-line cholangiocarcinoma with FGFR2 fusions has been terminated and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma [Phase 1]
Phase 1 trial evaluating gemcitabine and cisplatin with either ivosidenib or pemigatinib for unresectable or metastatic cholangiocarcinoma; …
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated tinengotinib (TT-00420) as a monotherapy and in combination therapy for patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy [Phase 2]
Phase 2 trial update for RRx-001 in second-line treatment of advanced cholangiocarcinoma; study terminated with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma [Phase 2]
Phase 2 clinical trial evaluating trifluridine/tipiracil in combination with irinotecan as second-line therapy for cholangiocarcinoma has co…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: A Study of TAS-120 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of futibatinib (TAS-120) in patients with advanced solid tumors, including cholangiocarcinoma, urothelial carcinoma, breas…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Multiorgan Metabolic Imaging Response Assessment of Abemaciclib [Phase 2]
Phase 2 trial update evaluating multiorgan metabolic imaging response assessment of abemaciclib.
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A safety and tolerability study of NC318 in advanced or metastatic solid tumors completed Phase 1/2 with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 trial evaluating a combo of DEB-TACE, lenvatinib, and pucotenlimab as conversion therapy for unresectable intrahepatic cholangiocarc…
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer [Phase 2]
Phase 2 trial of BBI503 in adults with advanced hepatobiliary cancer (hepatocellular carcinoma and cholangiocarcinoma) has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) [Phase 2]
Phase 2 trial evaluating niraparib in BAP1- and DDR-deficient neoplasms including mesothelioma and uveal melanoma has completed with results…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer [Phase 2]
Phase 2 clinical trial assessing PCI treatment with gemcitabine plus chemotherapy versus chemotherapy alone in patients with inoperable extr…
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers [Phase 2]
Phase 2 clinical trial assessing safety and tumoricidal effect of low-dose Foscan PDT in inoperable bile duct cancers (cholangiocarcinoma).
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC). [Phase 2]
Phase 2 trial evaluating trametinib plus hydroxychloroquine in KRAS-mutant biliary tract cancers was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer [Phase 2]
Phase 2 trial evaluating atezolizumab with or without cobimetinib in unresectable gallbladder carcinoma and metastatic cholangiocarcinoma; s…
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC [Phase 2]
A Phase 2 trial evaluating hepatic arterial infusion chemotherapy with oxaliplatin, 5-fluorouracil, and bevacizumab in combination with intr…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients [Phase 2]
Phase 2 trial update comparing durvalumab and tremelimumab with gemcitabine or gemcitabine/cisplatin versus gemcitabine/cisplatin in cholang…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating ramucirumab in advanced or metastatic biliary cancers that cannot be removed surgically; results completed…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Clinical Trial of Autologous Tcm Immunotherapy in ICC [Phase 2]
Phase 2 clinical trial update for autologous Tcm immunotherapy in cholangiocarcinoma.